Major Depressive Disorder Epidemiology Forecast to 2030 – ResearchAndMarkets.com

Major Depressive Disorder Epidemiology Forecast to 2030 – ResearchAndMarkets.com




Major Depressive Disorder Epidemiology Forecast to 2030 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Major Depressive Disorder – Epidemiology Forecast to 2030” drug pipelines has been added to ResearchAndMarkets.com’s offering.

This ‘Major Depressive Disorder (MDD)-Epidemiology Forecast – 2030’ report delivers an in-depth understanding of the Major Depressive Disorder (MDD), historical and forecasted epidemiology in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Major Depressive Disorder (MDD) Epidemiology

The Major Depressive Disorder (MDD) epidemiology division provides insights about the historical and current patient pool along with the forecasted trend for every seven major countries. It helps recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the report also provides the diagnosed patient pool and their trends and assumptions.

Key Findings

The disease epidemiology covered in the report provides historical as well as forecasted Major Depressive Disorder (MDD) epidemiology segmented as the 12 Months Prevalent cases of Major Depressive Disorder, Gender-specific prevalent case of Major Depressive Disorder, Severity-specific prevalent cases of Major Depressive Disorder and Relapsed/refractory cases of Major Depressive Disorder.

Country-wise Major Depressive Disorder (MDD) Epidemiology

The epidemiology segment also provides the Major Depressive Disorder (MDD) epidemiology data and findings across the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.

The total 12-month prevalent population of Major Depressive Disorder (MDD) Associated in 7MM countries was estimated to be 43,845,330 cases in 2020 and expected to decline at a CAGR of 0.45 % for the study period, i.e., 2018-2030.

  • As per the estimates, the US has the highest Incident population of Major Depressive Disorder (MDD)
  • Among the EU5 countries, France had the highest Incident population of Major Depressive Disorder (MDD). On the other hand, Spain had the lowest number of cases at 2,605,870 cases in 2020.

Key Assessments

  • Patient Segmentation
  • Disease Risk and Burden
  • Risk of disease by the segmentation
  • Factors driving growth in a specific patient population

Key Topics Covered:

1 Key Insights

2 Report Introduction

3 Major Depressive Disorder Market Overview at a Glance

3.1 Market Share (%) Distribution of MDD in 2018

3.2 Market Share (%) Distribution of MDD in 2030

4 Executive Summary of Major Depressive Disorder

5 Disease Background and Overview

5.1 Introduction

5.2 Sign and Symptoms

5.3 Types

5.4 Causes

5.5 Pathophysiology of Depression

5.6 Genetic basis of MDD

5.7 Biomarkers

5.8 Diagnosis and severity

5.8.1 The Diagnostic and Statistical Manual of Mental Disorders (DSM)

5.8.1.1 DSM-IV-TR Criteria for MDD

5.8.1.2 DSM-V: Diagnostic Criteria

5.8.1.3 Differential Diagnosis

5.8.1.4 DSM-IV-TR Criteria for Major Depressive Disorder

5.8.1.5 Depression Rating Scale

5.8.1.6 Montgomery-Asberg Depression Rating Scale (MADRS)

5.8.1.7 Depression Rating Scale (DRS)

6 Epidemiology and Patient Population

6.1 Key Findings

6.2 7MM Total 12 months Prevalent Patient Population of Major Depressive Disorder

6.3 The United States

6.3.1 12 Months Prevalent Cases of Major Depressive Disorder in the US

6.3.2 Gender-specific Prevalence of Major Depressive Disorder in the US

6.3.3 Severity Specific Cases of Major Depressive Disorder in the US

6.3.4 Relapse/Refractory Cases of Major Depressive Disorder in the US

6.4 EU5

6.4.1 Germany

6.4.2 France

6.4.3 Italy

6.4.4 Spain

6.4.5 United Kingdom

6.5 Japan

7. Appendix

For more information about this drug pipelines report visit https://www.researchandmarkets.com/r/oqekef

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900